Later, Clemente‐Casares et al. treated T1D mice with iron oxide nanoparticles coated with diabetogenic antigen peptide‐MHC class II complex.307 The treatment induced the differentiation of autoreactive T cells into antigen‐specific CD4+ Tregs. Here, CD4 is linked to type 1 diabetes mellitus.